UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 191

Sortiert nach

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

Haematologica (Roma), 2018-05, Vol.103 (5), p.874

2018

Volltextzugriff (PDF)

Predicting verbal reasoning from virtual community membership in a sample of Russian young adults

Heliyon, 2022-06, Vol.8 (6), p.e09664-e09664, Article e09664

2022

Volltextzugriff (PDF)

Corrigendum to “Predicting verbal reasoning from virtual community membership in a sample of Russian young adults” [Heliyon 8 (6) (2022) e09664]

Heliyon, 2022-08, Vol.8 (8), p.e10269-e10269, Article e10269

2022

Volltextzugriff (PDF)

P589: IMPLICATIONS OF REGISTRY DATA FOR ACUTE MYELOID LEUKEMIA (AML) TREATMENT AND CARE DURING THE COVID‐19 PANDEMIC

HemaSphere, 2023-08, Vol.7 (S3), p.e5950536-n/a

2023

Volltextzugriff (PDF)

Treatment and Reuse in Agriculture of Contaminated Water Using Supercritical Fluids

Environmental Sciences Proceedings, 2022-11, Vol.21 (1), p.76

2022

Volltextzugriff (PDF)

Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL Registry

EJHaem, 2020-07, Vol.1 (1), p.188-198

2020

Volltextzugriff (PDF)

Highly aligned electrospun nanofibers by elimination of the whipping motion

Journal of applied polymer science, 2012-08, Vol.125 (3), p.2433-2441

2012

Volltextzugriff (PDF)

Predicting post-operative delirium in elderly patients undergoing surgery for hip fracture

Psychogeriatrics, 2006-06, Vol.6 (2), p.43-48

2006

Volltextzugriff (PDF)

Implications for acute myeloid leukemia (AML) treatment and care during the COVID-19 pandemic: A Connect Myeloid Registry study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7021-7021

2023

Volltextzugriff (PDF)

Treatment Patterns and Outcomes of Patients with Primary or Secondary Acute Myeloid Leukemia By Type of Site (Academic or Community/Government): A CONNECT® Myeloid Registry Study

Blood, 2022-11, Vol.140 (Supplement 1), p.8923-8925

2022

Volltextzugriff (PDF)

Treatment Patterns and Outcomes of Patients with NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the CONNECT® Myeloid Disease Registry

Blood, 2022-11, Vol.140 (Supplement 1), p.11844-11846

2022

Volltextzugriff (PDF)

Assessing eligibility for non-intensive chemotherapy (IC) randomized clinical trials (RCT) in patients (pts) with newly diagnosed (ND) AML from the Connect Myeloid Disease Registry

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7029-7029

2022

Volltextzugriff (PDF)

Career guidance based on machine learning: social networks in professional identity construction

Procedia computer science, 2020, Vol.169, p.158-163

2020

Volltextzugriff (PDF)

Impact of Transfusions and Treatment Choice on Time Spent in Healthcare Facilities for Patients with Myelodysplastic Syndromes

Blood, 2022-11, Vol.140 (Supplement 1), p.9818-9820

2022

Volltextzugriff (PDF)

Treatment Patterns and Survival Outcomes of Patients with Acute Myeloid Leukemia Who Achieved Remission in the Connect ® Myeloid Disease Registry

Blood, 2021-11, Vol.138 (Supplement 1), p.279-279

2021

Volltextzugriff (PDF)

Connect ® Lymphoma Disease Registry: A US-Based, Prospective, Observational Cohort Study

Blood, 2021-11, Vol.138 (Supplement 1), p.1460-1460

2021

Volltextzugriff (PDF)

Treatment Patterns and Outcomes of Patients with Lower-Risk Myelodysplastic Syndromes in the Connect ® Myeloid Disease Registry

Blood, 2021-11, Vol.138 (Supplement 1), p.3686-3686

2021

Volltextzugriff (PDF)

POSTER: AML-547 Prognostic Effect of Co-Mutations on Patients With NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the Connect® Myeloid Registry

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S164-S164

2023

Volltextzugriff (PDF)

AML-547 Prognostic Effect of Co-Mutations on Patients With NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the Connect® Myeloid Registry

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S311-S312

2023

Volltextzugriff (PDF)

Health-related quality of life (HRQoL) in patients (pts) with myelodysplastic syndromes (MDS) in the Connect Myeloid Disease Registry

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.7040-7040

2021

Volltextzugriff (PDF)

Post-Remission Treatment (Tx) Patterns for Patients (Pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) in the Connect® MDS/AML Disease Registry

Blood, 2020-11, Vol.136 (Supplement 1), p.26-27

2020

Volltextzugriff (PDF)

AML-251 Overall Survival (OS) With Intensive Chemotherapy (IC) vs Non-IC in Patients With Newly Diagnosed (ND) AML from the Connect® Myeloid Disease Registry Ineligible for Randomized Clinical Trials (RCT)

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S229-S230

2022

Volltextzugriff (PDF)

Poster: AML-251 Overall Survival (OS) With Intensive Chemotherapy (IC) vs Non-IC in Patients With Newly Diagnosed (ND) AML from the Connect® Myeloid Disease Registry Ineligible for Randomized Clinical Trials (RCT)

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S131

2022

Volltextzugriff (PDF)

1 – 25 von 191

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(178)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(188)
Japanisch
(10)
Russisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Physical Sciences
(53)
Life Sciences & Biomedicine
(49)
Physics
(31)
Technology
(27)
Humans
(22)
Chemistry
(18)
Engineering
(17)
Physics, Applied
(15)
Female
(14)
Male
(13)
Engineering, Electrical & Electronic
(12)
Hematology
(11)
Diffraction
(10)
Middle Aged
(10)
Aged
(9)
Animals
(9)
Materials Science
(9)
Adult
(8)
Science & Technology - Other Topics
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

Predicting verbal reasoning from virtual community membership in a sample of Russian young adults

Corrigendum to “Predicting verbal reasoning from virtual community membership in a sample of Russian young adults” [Heliyon 8 (6) (2022) e09664]

P589: IMPLICATIONS OF REGISTRY DATA FOR ACUTE MYELOID LEUKEMIA (AML) TREATMENT AND CARE DURING THE COVID‐19 PANDEMIC

Treatment and Reuse in Agriculture of Contaminated Water Using Supercritical Fluids

Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL Registry

Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry

Highly aligned electrospun nanofibers by elimination of the whipping motion

Predicting post-operative delirium in elderly patients undergoing surgery for hip fracture

Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience

Implications for acute myeloid leukemia (AML) treatment and care during the COVID-19 pandemic: A Connect Myeloid Registry study

Treatment Patterns and Outcomes of Patients with Primary or Secondary Acute Myeloid Leukemia By Type of Site (Academic or Community/Government): A CONNECT® Myeloid Registry Study

Treatment Patterns and Outcomes of Patients with NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the CONNECT® Myeloid Disease Registry

Assessing eligibility for non-intensive chemotherapy (IC) randomized clinical trials (RCT) in patients (pts) with newly diagnosed (ND) AML from the Connect Myeloid Disease Registry

Career guidance based on machine learning: social networks in professional identity construction

Impact of Transfusions and Treatment Choice on Time Spent in Healthcare Facilities for Patients with Myelodysplastic Syndromes

Treatment Patterns and Survival Outcomes of Patients with Acute Myeloid Leukemia Who Achieved Remission in the Connect ® Myeloid Disease Registry

Connect ® Lymphoma Disease Registry: A US-Based, Prospective, Observational Cohort Study

Treatment Patterns and Outcomes of Patients with Lower-Risk Myelodysplastic Syndromes in the Connect ® Myeloid Disease Registry

POSTER: AML-547 Prognostic Effect of Co-Mutations on Patients With NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the Connect® Myeloid Registry

AML-547 Prognostic Effect of Co-Mutations on Patients With NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the Connect® Myeloid Registry

Health-related quality of life (HRQoL) in patients (pts) with myelodysplastic syndromes (MDS) in the Connect Myeloid Disease Registry

Post-Remission Treatment (Tx) Patterns for Patients (Pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) in the Connect® MDS/AML Disease Registry

AML-251 Overall Survival (OS) With Intensive Chemotherapy (IC) vs Non-IC in Patients With Newly Diagnosed (ND) AML from the Connect® Myeloid Disease Registry Ineligible for Randomized Clinical Trials (RCT)

Poster: AML-251 Overall Survival (OS) With Intensive Chemotherapy (IC) vs Non-IC in Patients With Newly Diagnosed (ND) AML from the Connect® Myeloid Disease Registry Ineligible for Randomized Clinical Trials (RCT)

Suchergebnisse filtern